The Department of Obstetrics and Gynecology at Massachusetts General Hospital consistently ranks among the nation’s best women’s health care providers.
Our clinicians have experience with a wide range of diseases and conditions and collaborate with other care providers and researchers across specialty areas and disciplines.
Our basic scientists in the Vincent Center for Reproductive Biology uncover strategies to improve women’s reproductive health across their lifespan.
Our clinical investigators in the Deborah Kelly Center for Outcomes Research ensure we deliver the right treatment to the right patient at the right time.
Through our comprehensive obstetrics, gynecology, in vitro fertilization and gynecologic cancer programs, we develop personalized care plans in partnership with patients and their families.
Collectively, these efforts make us uniquely positioned to gather the most visionary minds in medicine to bring to life new solutions in women’s health.
Imagine a future where ...
We prevent — rather than react to — ovarian cancer by offering new avenues of risk assessment and disease detection.
A holistic model of maternity care for appropriate patients can be developed and advanced, and pregnancy is treated as a healthy and important life event rather than as a medical condition.
Teams can build on new knowledge from research and clinical trials to develop preventive tools and effective treatments for individuals at risk for preterm labor and other pregnancy complications.
By capitalizing on the strengths of our general hospital and assembling a multidisciplinary team of experts to accelerate discovery and clinical progress, Mass General will make this future a reality.
Featured Story
Innovative Doula Program Improves Birth Outcomes for Women of Color
As part of a system-wide effort to decrease inequities, Massachusetts General Hospital launches new program that pairs doulas with pregnant women of color.
Investing in our faculty is essential to the care we deliver to our patients. We aim to endow 12 fellows in four sub-specialties, encouraging our outstanding early- and mid-career clinicians and nurses to think creatively, pursue promising research studies and develop specialized expertise. We also plan to establish endowed chairs for our more senior faculty to recognize their outstanding contributions to the field and provide flexible funding to advance their pioneering work.
Most pregnancies aren’t high risk and don’t require highly specialized care. Focused on healthy pregnancy and anticipated vaginal birth, this facility will ensure that Mass General can offer all women and their families the most appropriate level of care along with more complex care if an unexpected event or diagnosis occurs.
Establishing a translational research center for ovarian cancer will allow our physician-researchers to develop new markers and technologies for early-stage detection of ovarian cancer. This will enable care providers to tailor earlier treatments to each patient’s unique immunologic, genetic and pathologic profile.
We’ll create a more robust footprint in research and clinical trials by bringing together multidisciplinary research teams to develop preventive tools, early-detection measures and effective treatments for those at risk for gynecologic cancer, preterm labor and other pregnancy complications. These teams will also work to eliminate the disparities of maternal mortality and severe morbidity experienced by Black women during pregnancy.
To support the research, we also aim to launch a pregnancy biobank, which will allow us to better understand the many factors that affect fetal development and outcome and design treatments to keep mothers and their babies healthy and safe.
Our clinic supports treatment for pregnant women with substance use disorder by including partners, families and community members in a “wrap-around” approach to pregnancy, birth and early childhood.